A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia

Dendritic cell-based immunotherapy

(2016) Rachel L Sabado et al.   CELL RESEARCH

Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions

(2016) J. Rosenblatt et al.   Science Translational Medicine

Dendritic cell-based cancer immunotherapy for colorectal cancer

(2016) Mikio Kajihara et al.   WORLD JOURNAL OF GASTROENTEROLOGY

An update of current treatments for adult acute myeloid leukemia

(2015) H. Dombret et al.   BLOOD

Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989–2012

(2015) A G Dinmohamed et al.   LEUKEMIA

Neoantigens in cancer immunotherapy

(2015) T. N. Schumacher et al.   SCIENCE

Dendritic Cell-Based Vaccination in Cancer: Therapeutic Implications Emerging from Murine Models

(2015) Soledad Mac Keon et al.   Frontiers in Immunology

Inducing Antitumor T Cell Immunity: Comparative Functional Analysis of Interstitial Versus Langerhans Dendritic Cells in a Human Cell Line Model

(2014) S. J. A. M. Santegoets et al.   JOURNAL OF IMMUNOLOGY

Treatment of acute myeloid leukaemia

(2013) A. K. Burnett   CLINICAL MEDICINE

High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study

(2013) Monique Terwijn et al.   JOURNAL OF CLINICAL ONCOLOGY

Genomic applications in the clinic: use in treatment paradigm of acute myeloid leukemia

(2013) R. F. Schlenk et al.   Hematology-American Society of Hematology Education Program

Dendritic Cell-Based Immunotherapy for Myeloid Leukemias

(2013) Christian M. Schürch et al.   Frontiers in Immunology

Dendritic Cells in Cancer Immunotherapy Clinical Trials: Are We Making Progress?

(2013) Lisa H. Butterfield   Frontiers in Immunology

T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment

(2012) Saskia J. A. M. Santegoets et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Increasing the efficacy of tumor cell vaccines by enhancing cross priming

(2012) Brian M. Andersen et al.   CANCER LETTERS

Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia

(2012) S Anguille et al.   LEUKEMIA

Trial watch

(2012) Lorenzo Galluzzi et al.   OncoImmunology

Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis

(2011) E W Duiker et al.   BRITISH JOURNAL OF CANCER

Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy

(2011) Rieneke van de Ven et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Cross-priming of CD8+ T cells in vivo by dendritic cells pulsed with autologous apoptotic leukemic cells in immunotherapy for elderly patients with acute myeloid leukemia

(2011) Toshio Kitawaki et al.   EXPERIMENTAL HEMATOLOGY

Long-Term Prognosis of Acute Myeloid Leukemia According to the New Genetic Risk Classification of the European LeukemiaNet Recommendations: Evaluation of the Proposed Reporting System

(2011) Christoph Röllig et al.   JOURNAL OF CLINICAL ONCOLOGY

Therapeutic Advances in Acute Myeloid Leukemia

(2011) Alan Burnett et al.   JOURNAL OF CLINICAL ONCOLOGY

Defining the critical hurdles in cancer immunotherapy

(2011) Bernard A Fox et al.   Journal of Translational Medicine

A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS

(2009) U. Keilholz et al.   BLOOD

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines

(2008) Tanja D. de Gruijl et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Local Administration of PF-3512676 CpG-B Instigates Tumor-Specific CD8+ T-Cell Reactivity in Melanoma Patients

(2008) B. G. Molenkamp et al.   CLINICAL CANCER RESEARCH

Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia

(2008) D. Messerer et al.   HAEMATOLOGICA

Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression

(2008) Inge S. van Houdt et al.   INTERNATIONAL JOURNAL OF CANCER

Human dendritic cell line models for DC differentiation and clinical DC vaccination studies

(2008) Saskia J. A. M. Santegoets et al.   JOURNAL OF LEUKOCYTE BIOLOGY

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

(2008) J. Yuan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA